FDA Drug Shortages
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Dextrose 5% Injection
Status: Currently in Shortage
»Date first posted:
02/14/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric
B. Braun Medical Inc. (New 02/16/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% 500 mL Excel Bag L5101 (NDC 0264-7510-10) | Product on allocation for contracted customers | Other | |
| 5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00) | Product on allocation for contracted customers | Other | |
| 5% 250 mL Excel Bag L5102 (NDC 0264-7510-20) | Product on allocation for contracted customers | Other | |
| 5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32) | Product available | ||
| 5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31) | Product available | ||
| 10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00) | Product available | ||
| 10% 500 mL Excel Bag L5201 (NDC 0264-7520-10) | Product available | ||
| 10% 250 mL Excel Bag L5202 (NDC 0264-7520-20) | Product on allocation for contracted customers | Other |
Baxter Healthcare (Revised 04/27/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10) | Available on allocation | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41) | Available on allocation | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11) | Available on allocation | ||
| 5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31) | Available on allocation | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48) | Available on allocation | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18) | Available on allocation. Recovery late April 2022 | ||
| 5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38) | Available on allocation | ||
| 5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11) | Available on allocation | ||
| 5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30) | Limited supply on allocation, recovery 2023 | Demand increase | |
| 5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30) | Available on allocation | ||
| 5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18) | Limited supply on allocation, recovery late May 2022 | Demand increase | |
| 5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10) | Available on allocation | ||
| 5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02) | Available on allocation | ||
| 5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30) | Available on allocation | ||
| 5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03) | Available on allocation | ||
| 5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20) | Available on allocation |
Fresenius Kabi USA, LLC (Revised 05/04/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61) | Backordered. Next release May 2022. | Increase in Demand | |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74) | Backordered. Next release July 2022. | Increase in Demand | |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75) | Backordered. Next release May 2022. | Increase in Demand | |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10) | Backordered. Next release August 2022. | Increase in Demand | |
| 5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50) | Backordered. Next release June 2022. | Increase in Demand |
Hospira, Inc., a Pfizer Company (Revised 04/29/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66) | Next Delivery: May 2022; Estimated Recovery: June 2022 | Demand increase for the drug | |
| 100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67) | Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: September 2022 | Check wholesaler for availability; Shortage per Manufacturer: Manufacturing delay | Other |
| 250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02) | Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: September 2022 | Check wholesaler for availability; Shortage per Manufacturer: Manufacturing delay | Other |
ICU Medical, Inc. (Revised 05/05/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13) | Allocation | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23) | Unavailable | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36) | Unavailable | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37) | Allocation | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | Demand increase for the drug |
| 5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 50 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-06) (ICU Medical NDC 0990-7923-06) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 100 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-11) (ICU Medical NDC 0990-7923-11) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 250 mL VisIV™ Container (Legacy Hospira NDC 0409-7922-25) (ICU Medical NDC 0990-7922-25) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. | |
| 5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09) | Available | ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English